Press Releases

Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the results of its Board of Directors Election for the term beginning January 1, 2019. In the fall of 2018, PDA’s 10,500 members had an opportunity to participate in the election of new directors.

Bethesda, Md. – The Parenteral Drug Association (PDA) is pleased to announce the formation of a PDA technical report team and a task force to advance projects to assist pharmaceutical manufacturers in key areas. Both projects were approved by the PDA Science Advisory Board and have spun out of PDA’s umbrella Manufacturing Science and Operations ProgramSM, which is an advisory body to PDA of leading experts in pharmaceutical manufacturing.

Bethesda, Md. – The Parenteral Drug Association (PDA) announced the formation of the Pacific Northwest Chapter, its newest chapter. The PDA Board of Directors voted to accept the chapter’s charter and its board of volunteer officers at its September meeting in Washington, DC. The chapter will provide a local forum through which technical professionals in Washington, Oregon, Idaho, Alaska, and British Columbia can support the advancement of pharmaceutical and biopharmaceutical science and technology.

Bethesda, Md., August 17, 2018 – The Parenteral Drug Association (PDA) is pleased to announce the agenda for the 2018 PDA Biosimilars Workshop, “Getting it Right the First Time for Biosimilar Marketing Applications,” which will be held at the Renaissance Washington DC Downtown Hotel, Sept. 26 – 27.

Bethesda, Md. – The Parenteral Drug Association’s (PDA) Manufacturing Science and Operations ProgramSM (MSOP) Manufacturing Intelligence Task Force will present an update on its activities on Tuesday June 26 at 15:20 CET during the PDA Europe 3rd Annual Meeting at the Berlin Marriott.

Intelligence report analyzes link between post approval change regulations and drug shortages

Bethesda, Md., June 4,2018 – The Parenteral Drug Association (PDA) is advancing its activities involving the recent release of the draft revision to EU GMP Guideline Annex 1, the European guideline for sterile medicinal products with a recent in-depth workshop on the topic and the formation of a consortium to address pre-use and post-sterilization integrity testing for sterilizing grade filters (PUPSIT).

Bethesda, Md., May 14, 2018 – The Parenteral Drug Association, Inc. (PDA) is pleased to announce that President & CEO Richard Johnson and past Chairs Martin Van Trieste, Maik Jornitz, Harold Baseman, and James Agalloco have been recognized by The Medicine Maker as among the top 25 “Industry Influencers” in 2018.

Bethesda, Md., May 7, 2018 – The Parenteral Drug Association (PDA) and the International Society of Pharmaceutical Engineers (ISPE) announced today that they have signed a Memorandum of Understanding (MOU) to exchange information regarding their respective efforts on Quality Metrics and Quality Culture.

Bethesda, Md., April 30, 2018 – The Parenteral Drug Association (PDA) is proud to present its inaugural Pharmacopoeia Conference held at the Renaissance Wien Hotel, May 29-30, Vienna, Austria, which features lectures from representatives of the pharmacopoeias for Europe, the United States, Russia, China, Japan, India, and Ghana. The European Directorate for Quality of Medicines & Healthcare (EDQM) is chairing the conference.

Bethesda, Md., April 23, 2018 – The Parenteral Drug Association (PDA) is pleased to announce that Tina Morris, PhD, has been named Vice President of Scientific and Regulatory Affairs, effective June 4, 2018. Dr. Morris currently serves as Sr. VP of Compendial Sciences at the U.S. Pharmacopeia, with whom she has worked for 15 years.

Bethesda, Md., April 13, 2018 – The Parenteral Drug Association (PDA) announced today that it is expanding its pharmaceutical packaging program with the addition of two trainings in Seoul, Korea and the publication of a book and a survey on pharmaceutical glass.

Bethesda, Md., March 16, 2016 – The Parenteral Drug Association (PDA) is pleased to announce the official launch of its Quality Culture Transformation Program for pharmaceutical manufacturers. Enrollment in the Quality Culture Transformation Program gives companies access to four tools to measure and ultimately improve their commitment to quality.

Bethesda, Md., January 30, 2018 – The Parenteral Drug Association (PDA) today announced its 2018 events calendar, which includes 35 conferences and workshops. These events are developed by all-volunteer subject-matter experts who work with PDA staff to help educate pharmaceutical professionals on important topics related manufacturing science, quality and regulatory affairs.